As on Thursday, AMGEN Inc (NASDAQ: AMGN) started slowly as it slid -1.41% to $274.33, before settling in for the price of $278.26 at the close. Taking a more long-term approach, AMGN posted a 52-week range of $257.80-$346.85.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
The Healthcare sector firm’s twelve-monthly sales growth has been 3.42% for the last half of the decade. Meanwhile, its Annual Earning per share during the time was -0.22%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 4.96%. This publicly-traded company’s shares outstanding now amounts to $537.50 million, simultaneously with a float of $536.15 million. The organization now has a market capitalization sitting at $147.46 billion. At the time of writing, stock’s 50-day Moving Average stood at $308.36, while the 200-day Moving Average is $305.59.
AMGEN Inc (AMGN) Ownership Facts and Figures
Another important factor to analyze is how key investors are playing towards the stock of the Drug Manufacturers – General industry. AMGEN Inc’s current insider ownership accounts for 0.26%, in contrast to 78.01% institutional ownership. According to the most recent insider trade that took place on May 03 ’24, this organization’s SVP & CCO sold 2,117 shares at the rate of 313.09, making the entire transaction reach 662,802 in total value, affecting insider ownership by 9,883.
AMGEN Inc (AMGN) Earnings and Revenue Records
AMGEN Inc’s EPS increase for this current 12-month fiscal period is 4.96% and is forecasted to reach 20.70 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will increase by 5.00% through the next 5 years, which can be compared against the -0.22% growth it accomplished over the previous five years trading on the market.
AMGEN Inc (NASDAQ: AMGN) Trading Performance Indicators
Let’s observe the current performance indicators for AMGEN Inc (AMGN). It’s Quick Ratio in the last reported quarter now stands at 0.96. The Stock has managed to achieve an average true range (ATR) of 8.20. Alongside those numbers, its PE Ratio stands at $35.13, and its Beta score is 0.54. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 4.56. Similarly, its price to free cash flow for trailing twelve months is now 23.47.
In the same vein, AMGN’s Diluted EPS (Earnings per Share) trailing twelve months is recorded 7.81, a figure that is expected to reach 5.04 in the next quarter, and analysts are predicting that it will be 20.70 at the market close of one year from today.
Technical Analysis of AMGEN Inc (AMGN)
Through scrutinizing the latest numbers posted by the [AMGEN Inc, AMGN], it can be observed that its last 5-days Average volume of 3.95 million was better the volume of 2.6 million, it posted the year before. During the previous 9 days, stock’s Stochastic %D was recorded 48.50% While, its Average True Range was 8.26.
Raw Stochastic average of AMGEN Inc (AMGN) in the period of the previous 100 days is set at 18.56%, which indicates a major fall in contrast to 41.82% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 32.03% that was higher than 25.75% volatility it exhibited in the past 100-days period.
